March 04, 2025

Updated Colonoscopy Guidelines Released by Task Force

These guidelines represent a comprehensive update to the 2014 recommendations, developed following a thorough literature review and consensus among experts from the three major GI societies.

Conexiant

March 04, 2025

Can Tart Cherry Juice Relieve Ulcerative Colitis Symptoms?

Randomized trial shows twice-daily supplementation improves quality of life, reduces inflammation markers, and lessens symptom severity in patients with mild to moderate disease.

Conexiant

March 04, 2025

Higher Absenteeism Linked to Functional GI Disorders

Researchers found that children with functional gastrointestinal disorders experience higher school absenteeism than those with organic diseases, suggesting absenteeism could provide diagnostic insight.

Conexiant

March 03, 2025

More States Fast Track Foreign-Trained Physicians

Since 2023, nine states have waived U.S. residency requirements for some foreign-trained physicians, with more states considering similar changes.

KFF Health News

March 03, 2025

Omalizumab Bests Oral Immunotherapy for Food Allergies

"These differences were largely driven by the high rate of adverse events leading to study discontinuation in the OIT-treated participants, despite receiving omalizumab treatment at the initiation of therapy."

Conexiant

February 26, 2025

New Medical Malpractice Rules Issued by American Law Institute

The American Law Institute's first restatement of medical malpractice law shifts focus from customary practice to evidence-based medicine.

Conexiant

February 25, 2025

FDA Delays Update on 'Healthy' Label

The finalization of new criteria for the "healthy" nutrient content claim on food labels has been delayed, allowing more time for regulatory review of standards that could significantly influence labeling practices and help reduce diet-related chronic diseases.

Conexiant

February 24, 2025

Do Black Female Doctors Die Earlier?

New JAMA Internal Medicine study finds Black female physicians face higher mortality rates than White women in general population.

Conexiant

February 24, 2025

Subcutaneous Infliximab Matches IV Efficacy in IBD

Switching to subcutaneous infliximab was associated with high treatment persistence, stable disease course, and an acceptable safety profile, according to researchers.

Conexiant